Table 1. Preclinical PK and Projected Human PK of Compound GNE-6893.
Species | LM CLhepa | Hep CLhepa | PPBb | CL | Vss (L/kg) | t1/2 (h) | %F |
---|---|---|---|---|---|---|---|
Mouse | 61 | 47 | 94.7 | 34 | 1.8 | 1.7 | 37 |
Rat | 32 | 29 | 90.6 | 39 | 2.2 | 1.3 | 30 |
Dogc | 19 | 14 | 85.8 | 14 | 2.2 | 2.5 | 46 |
Cynod | 29 | 9.9 | 88.4 | 14 | 1.9 | 1.9 | 53 |
Human (predicted) | 14 | 5.9 | 95.5 | (5.9) | (2.1) | (4.1) | (43) |
LM and Hep clearance values (mL/min/kg) represent arithmetic means of two or more determinations.
PPB = plasma protein binding (%).
Dog PK: Beagle, 0.5 mg/kg i.v. dose or 0.5 mg/kg p.o. dose, plasma clearance measured in mL/min/kg.
Cynomolgus Monkey PK: 0.5 mg/kg i.v. dose or 0.5 mg/kg p.o. dose, plasma clearance measured in mL/min/kg.